EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Additive Glucagonotropic and Insulinotropic Effects of Glucose‐Dependent Insulinotropic Polypeptide and Alanine in Fasted Healthy Men

Julie Warnøe iD, Aliya M Thomas, David S Mathiesen iD, Mathilde K Preskou, Joachim Størling, Mikkel B Christensen, Bolette Hartmann, Jens J Holst iD, Samuel A J Trammell, Jonathan E Campbell iD, Thomas F Dejgaard iD, Asger B Lund und 2 weitere

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11095-11106

DOI: 10.1111/dom.71273 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 08.09.2026. Verfasst von Julie Warnøe und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Hauptthemen laut MEDLINE: Gastric Inhibitory Polypeptide, Glucagon, Alanine, Blood Glucose. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Hypothesis Glucose‐dependent insulinotropic polypeptide (GIP) is a bidirectional glucose‐stabilising hormone potentiating insulin secretion at high glucose levels and glucagon secretion during normal‐to‐low plasma glucose levels. Preclinically, GIP and the amino acid alanine show synergistic glucagonotropic effects at low glucose levels. We therefore evaluated the separate and combined effects of GIP and alanine infusions on plasma glucose, glucagon and C‐peptide in fasted, healthy men.

Methods

In this placebo‐controlled, randomised, double‐blind crossover study, 10 healthy men (mean age 22.9 ± 2.82 years, BMI 23.7 ± 2.07 kg/m 2 ) underwent four experimental days involving 90‐min i.v. infusions of saline + GIP (6 pmol/kg/min for 10 min, then 4 pmol/kg/min for 80 min), alanine + saline (28 μmol/kg/min), alanine + GIP, and saline + saline after a 10‐h fast.

Results

As expected, the infusions increased circulating levels of alanine and GIP according to the intervention. Alanine increased glucagon secretion, while GIP induced a more moderate glucagonotropic effect. The combination of alanine and GIP resulted in an additive increase in glucagon secretion with bsAUC glucagon being 38% ± 5% higher compared to alanine + saline ( p > 0.01) and 83% ± 7% higher than saline + GIP ( p < 0.01). C‐peptide was likewise higher with alanine + GIP than with either single infusion ( p < 0.01). Saline + GIP transiently raised C‐peptide and resulted in lowered plasma glucose compared with placebo ( p < 0.01) and alanine + saline and alanine + GIP ( p < 0.01). Conclusions/Interpretation In fasting healthy men, both GIP and alanine stimulate pancreatic hormone secretion, and combined administration additively enhances glucagon and C‐peptide responses. Alanine availability modulates the metabolic actions of GIP and may influence its glucose‐regulatory effects under fasting conditions. Trial Registration: ClinicalTrials.gov identifier: NCT06881472.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric Inhibitory PolypeptideGlucagonAlanineBlood GlucoseInsulinHumansMaleCross-Over StudiesYoung AdultDouble-Blind MethodAdultC-PeptideFastingInsulin SecretionInfusions, IntravenousHealthy VolunteersDrug Synergism

Stichwörter der Autor:innen

amino acidsglucagonglucose‐dependent insulinotropic polypeptideinsulin secretionrandomised controlled crossover study

Substanzen

Gastric Inhibitory PolypeptideGlucagonAlanineBlood GlucoseC-PeptideInsulin

Autor:innen und Institutionen

  • Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
  • Steno Diabetes Center Copenhagen, University of Copenhagen, Herlev, Denmark.
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Novo Nordisk Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Julie Warnøe, David S Mathiesen, Jens J Holst, Jonathan E Campbell, Thomas F Dejgaard, Lærke S Gasbjerg

Zitieren

APA

Warnøe, J., Thomas, A. M., Mathiesen, D. S., Preskou, M. K., Størling, J., Christensen, M. B., Hartmann, B., Holst, J. J., Trammell, S. A. J., Campbell, J. E., Dejgaard, T. F., Lund, A. B., Knop, F. K., & Gasbjerg, L. S. (2026). Additive Glucagonotropic and Insulinotropic Effects of Glucose‐Dependent Insulinotropic Polypeptide and Alanine in Fasted Healthy Men. Diabetes, Obesity and Metabolism, 28(12), 11095-11106. https://doi.org/10.1111/dom.71273

Vancouver

Warnøe J, Thomas AM, Mathiesen DS, Preskou MK, Størling J, Christensen MB, et al. Additive Glucagonotropic and Insulinotropic Effects of Glucose‐Dependent Insulinotropic Polypeptide and Alanine in Fasted Healthy Men. Diabetes, Obesity and Metabolism. 2026;28(12):11095-11106. doi:10.1111/dom.71273

BibTeX
@article{Warne2026,
  author = {Warnøe, Julie and Thomas, Aliya M and Mathiesen, David S and Preskou, Mathilde K and Størling, Joachim and Christensen, Mikkel B and Hartmann, Bolette and Holst, Jens J and Trammell, Samuel A J and Campbell, Jonathan E and Dejgaard, Thomas F and Lund, Asger B and Knop, Filip K and Gasbjerg, Lærke S},
  title = {Additive Glucagonotropic and Insulinotropic Effects of Glucose‐Dependent Insulinotropic Polypeptide and Alanine in Fasted Healthy Men},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {12},
  pages = {11095--11106},
  doi = {10.1111/dom.71273}
}
Kostenlos starten →